Digitalisation of Medicines Manufacturing: Challenge Fund event
UK businesses can apply for a share of up to £8m from the Industrial Strategy Challenge Fund to conduct capital infrastructure improvements to their current capability in medicines manufacturing.
KTN is working with Innovate UK on a webinar and an engagement event to update companies, academics and organisations looking to put proposals into this call.
Join Innovate UK and the KTN on the webinar on 11th September at 12.30 by registering for the webinar here or by attending in person the event on 21st September at the Ambassadors Hotel London (register below to attend in person).
Some scope details are listed below, or read the full document here.
Innovate UK, as part of UK Research and Innovation, will invest up to £8 million in innovation projects to enhance the manufacture of medicinal products using digitalisation technology.
The aim of this competition is to enable existing manufacturing operations to improve their scope and/or efficiency and effectiveness through the application of capital improvements that are enabled by digital technology. Your proposal should show the justification for any improvements that are foreseen and the reason for selecting the specific enhancement that is planned.
This competition is for capital investment, including refurbishment and equipment. Funding cannot go towards salaries or consumables. Capital can include the cost of setting up equipment but not the costs of maintenance or staff. This competition is to be conducted in a single phase within Financial Year 2018-19. Project work must be completed by 31st March 2019.
Projects may be led by an SME or by a larger company. Bids by a single company or by more than one company acting in collaboration will be accepted. The maximum funding for eligible project costs is up to 50% for businesses of any size.
Further details on the competition can be viewed here, which supercedes the above outline, and any other information given previously.
For further information on this competition please contact Sarah Goulding, Specialist, Medicines and Advanced Therapies.